-
公开(公告)号:US20240355476A1
公开(公告)日:2024-10-24
申请号:US18761410
申请日:2024-07-02
IPC分类号: G16H50/20 , C12Q1/6809 , C12Q1/6827 , C12Q1/6837 , C12Q1/6886 , G16H50/30
CPC分类号: G16H50/20 , C12Q1/6809 , C12Q1/6827 , C12Q1/6837 , C12Q1/6886 , G16H50/30 , C12Q2600/106 , C12Q2600/112 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158
摘要: Embodiments are directed to kits and methods of treating a breast cancer patient with a glucocorticoid receptor antagonist with or without an anticancer agent or compound after the patient has been determined to be susceptible to treatment with the glucocorticoid receptor antagonist.